Biogen
BIIB
₹11,346
Share price
-0.24%
Change (1 day)
-39.50%
Change (1 year)
Categories
Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.
Stock split history for Biogen (BIIB)
Biogen stock (symbol: BIIB) underwent a total of 2 stock splits.
The most recent stock split occurred on January 18th, 2001.
One BIIB share bought prior to December 21st, 1999 would equal to 6 BIIB shares today.
Stock split list
| Date | Split | Multiple | Cumulative multiple |
|---|---|---|---|
| 2001-01-18 | 3:1 | x3 | x6 |
| 1999-12-21 | 2:1 | x2 | x2 |
Stock splits for similar companies or competitors
| Company | number of stock splits | Cumulative multiple | Country |
|---|---|---|---|
 Amgen AMGN | 5 | x48 | 🇺🇸 USA |
 Gilead Sciences GILD | 5 | x32 | 🇺🇸 USA |
 AbbVie ABBV | 0 | N/A | 🇺🇸 USA |
 Pfizer PFE | 6 | x51 | 🇺🇸 USA |
 Johnson & Johnson JNJ | 6 | x144 | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | 2 | N/A | 🇺🇸 USA |
 Sanofi SNY | 0 | N/A | 🇫🇷 France |
 Bio-Rad Laboratories BIO | 5 | x14 | 🇺🇸 USA |
 Illumina ILMN | 2 | x2 | 🇺🇸 USA |
 Qiagen QGEN | 3 | x8 | 🇳🇱 Netherlands |